Lakhani Pharma Pvt. Ltd

Home
Pakistan
Rahimyar Khan
Lakhani Pharma Pvt. Ltd

Lakhani Pharma (Pvt.) Our aim to contribute better healthcare.

Ltd is a health care company whose
Slogan is Health for Life is committed to manufacture pharmaceutical Product of highest quality to prevent and cure diseases.

04/06/2025

Laksol™-NS || 0.9% Sodium Chloride Intravenous Infusion B.P.|| Lakhani Pharma(pvt)Ltd
Therapeutic Segment: Electrolytes
Generic Name: 0.9% Sodium Chloride Intravenous Infusion B.P.
Clinical Indication:
This medicine is a solution of sodium chloride administered through a tube placed into a vein (intravenous drip). It contains sodium chloride at a concentration similar to the concentration of salts in blood.
The patient will receive it when:
• Having a low level of body fluids (isotonic dehydration)
• Having low level of body fluids and blood sodium level is abnormally low (hypotonic dehydration)
• Having a low blood chloride level and blood is very alkaline (hypochloremic alkalosis)
• Have lost sodium or chloride
• Vehicle or diluent of compatible drugs for parenteral administration
This solution is also used:
• For immediate replenishment of blood volume after blood loss,
• As a vehicle to deliver other electrolytes or medicinal products,
• For treatment of wounds and moistening of wound tamponades and dressings.
Available as:
IV Drip/Ampoule
• 100ml
• 500ml
• 1000ml
Pharma is dedicated to providing high-quality pharmaceutical products to promote health and well-being. Our commitment to excellence and innovation drives us to constantly improve and expand our product offerings. With a focus on delivering safe and effective medications, we strive to contribute to the health and happiness of individuals and communities. Join us in our mission to make health a top priority and to ensure that everyone has access to the essential medicines they need.

03/06/2025

Laksol™-RLD
Therapeutic Segment: Electrolytes
Generic Name: Lactated Ringer and 5% Glucose Injection U.S.P.
Clinical Indication:
LAKSOL-RL (Lactated Ringer and 5% Glucose Injection)has value as a source of water for hydration, electrolytes and calories.
• Lactated Ringer’s and 5% Dextrose Injection, USP has value as a source of water, electrolytes, and calories. It is capable of inducing diuresis depending on the clinical condition of the patient.
• Lactated Ringer’s and 5% Dextrose Injection, USP produce a metabolic alkalinizing effect.
• Lactate is a substrate for gluconeogenesis. Administration of solutions containing dextrose and lactate should be used with caution in patients with impaired glucose tolerance and diabetes mellitus, as it may result in hyperglycemia.
• As for other calcium-containing infusion solutions, concomitant administration of ceftriaxone and Lactated Ringer’s and 5% Dextrose Injection, USP is contraindicated in newborns (≤ 28 days of age), even if separate infusion lines are used (risk of fatal ceftriaxone-calcium salt precipitation in the neonate’s bloodstream).
• In patients older than 28 days (including adults), ceftriaxone must not be administered simultaneously with intravenous calcium-containing solutions, including Lactated Ringer’s and 5% Dextrose Injection, USP, through the same infusion line (e.g., via Y-connector).
• Lactated Ringer’s and 5% Dextrose Injection, USP is contraindicated in patients with a known hypersensitivity to sodium lactate.
The choice of the specific electrolyte and glucose concentration, dosage, volume, rate and duration of administration depends on the age, weight, clinical condition of the patient and concomitant therapy. It should be determined by a physician.
Available as:
IV Drips
• 500ml
• 1000ml

31/05/2025

KSOL-DS (5% Glucose and 0.9% Sodium Chloride I.V. Infusion B.P.) is a solution that contains glucose indicated for the treatment of sodium depletion, extracellular dehydration or hypovolemia in cases where a supply of water and carbohydrates is required due to restriction of the intake of fluids and electrolytes by normal routes.
The choice of the specific sodium chloride and glucose concentration, dosage, volume, rate and duration of administration depends on the age, weight, clinical condition of the patient and concomitant therapy. It should be determined by a physician.
Available as:
IV Drips
• 500ml
• 1000ml

30/05/2025

Laksol™-RLD
Therapeutic Segment: Electrolytes
Generic Name: Lactated Ringer and 5% Glucose Injection U.S.P.
Clinical Indication:
LAKSOL-RL (Lactated Ringer and 5% Glucose Injection)has value as a source of water for hydration, electrolytes and calories.
• Lactated Ringer’s and 5% Dextrose Injection, USP has value as a source of water, electrolytes, and calories. It is capable of inducing diuresis depending on the clinical condition of the patient.
• Lactated Ringer’s and 5% Dextrose Injection, USP produces a metabolic alkalinizing effect.
• Lactate is a substrate for gluconeogenesis. Administration of solutions containing dextrose and lactate should be used with caution in patients with impaired glucose tolerance and diabetes mellitus, as it may result in hyperglycemia.
• As for other calcium-containing infusion solutions, concomitant administration of ceftriaxone and Lactated Ringer’s and 5% Dextrose Injection, USP is contraindicated in newborns (≤ 28 days of age), even if separate infusion lines are used (risk of fatal ceftriaxone-calcium salt precipitation in the neonate’s bloodstream).
• In patients older than 28 days (including adults), ceftriaxone must not be administered simultaneously with intravenous calcium-containing solutions, including Lactated Ringer’s and 5% Dextrose Injection, USP, through the same infusion line (e.g., via Y-connector).
• Lactated Ringer’s and 5% Dextrose Injection, USP is contraindicated in patients with a known hypersensitivity to sodium lactate.
The choice of the specific electrolyte and glucose concentration, dosage, volume, rate and duration of administration depends on the age, weight, clinical condition of the patient and concomitant therapy. It should be determined by a physician.
Available as:
IV Drips
• 500ml
• 1000ml

28/05/2025

Laksol™-RL
Therapeutic Segment: Electrolytes
Generic Name: Lactated Ringer’s Injection U.S.P.
Clinical Indication:
LAKSOL-RL (Lactated Ringer’s Injection) provides electrolytes and is a source of water for hydration. It is capable of inducing diuresis.
Lactated Ringer's Injection is indicated to:
• This solution is indicated for use in adults and pediatric patients as a source of electrolytes and water for hydration.
• This solution is contraindicated where the administration of sodium, potassium, calcium, lactate, or chloride could be clinically detrimental.
• Lactate administration is contraindicated in severe metabolic acidosis or alkalosis and in severe liver disease or anoxic states which affect lactate metabolism.
• Solutions containing lactate are not for use in the treatment of lactic acidosis. Solutions containing lactate should be used with great care in patients with metabolic or respiratory alkalosis and in those conditions in which there is an increased level or an impaired utilization of lactate, such as severe hepatic insufficiency.
• Solutions containing sodium ions should be used with great care, if at all, in patients with congestive heart failure, severe renal insufficiency, and clinical states in which there is sodium retention with edema.
• This solution should be used with care in patients with hypervolemia, renal insufficiency, urinary tract obstruction, or impending or frank cardiac decompensation.
Available as:
IV Drips
• 500ml
• 1000ml

25/05/2025

Laksol™-DS
Therapeutic Segment: Carbohydrates & Electrolytes
Generic Name: 5% Glucose and 0.9% Sodium Chloride Intravenous Infusion B.P.
Clinical Indication:
LAKSOL-DS (5% Glucose and 0.9% Sodium Chloride I.V. Infusion B.P.) is a solution that contains glucose indicated for the treatment of sodium depletion, extracellular dehydration or hypovolemia in cases where a supply of water and carbohydrates is required due to restriction of the intake of fluids and electrolytes by normal routes.
The choice of the specific sodium chloride and glucose concentration, dosage, volume, rate and duration of administration depends on the age, weight, clinical condition of the patient and concomitant therapy. It should be determined by a physician.
Available as:
IV Drips
• 500ml
• 1000ml

24/05/2025

Laksol™-G5
Therapeutic Segment: Carbohydrates
Generic Name: 5% Glucose anhydrous Intravenous Infusion B.P.
Clinical Indication:
LAKSOL-5 is a solution that contains glucose; it is indicated for the treatment of carbohydrate and fluid depletion in both adult and pediatric populations. Glucose 5% is also used as a vehicle and diluent for compatible medicinal products for parenteral administration.
The following are primary indications for the use of 5% Glucose infusion:
• For fluid and carbohydrate depletion wherever a non-electrolyte fluid is required
• In the treatment of hypoglycemia.
• In the treatment of acute diarrhoeal disease.
• As a vehicle for the administration of other medications.
The infusion of hypertonic glucose (≥ 10%) preparations is contraindicated in patients:
• With hypersensitivity to the active substance or to any of the excipients
• Having intracranial or intraspinal haemorrhage.
• With delirium tremens or those who are severely dehydrated.
• Who are anuric.
• With diabetic coma.
Dosage will be dependent upon individual patient circumstances, such as age, weight and clinical condition, and is determined by the attending physician.
This solution is also used:
• For immediate replenishment of blood volume after blood loss,
• As a vehicle to deliver other electrolytes or medicinal products,
• For treatment of wounds and moistening of wound tamponades and dressings.
•
Available as:
IV Drips
• ml
• ml
• ml

22/05/2025

Laksol™-DS
Therapeutic Segment: Carbohydrates & Electrolytes
Generic Name: 5% Glucose and 0.9% Sodium Chloride Intravenous Infusion B.P.
Clinical Indication:
LAKSOL-DS (5% Glucose and 0.9% Sodium Chloride I.V Infusion B.P)is a solution that contains glucose indicated for the treatment of sodium depletion, extracellular dehydration or hypovolaemia in cases where supply of water and carbohydrates is required due to restriction of the intake of fluids and electrolytes by normal routes.
The choice of the specific sodium chloride and glucose concentration, dosage, volume, rate and duration of administration depends on the age, weight, clinical condition of the patient and concomitant therapy. It should be determined by a physician.
Available as:
IV Drips
• 500ml
• 1000ml

21/05/2025

Laksol™-G5
Therapeutic Segment: Carbohydrates
Generic Name: 5% Glucose anhydrous Intravenous Infusion B.P.
Clinical Indication:
LAKSOL-5 is a solution that contains glucose it indicated for the treatment of carbohydrate and fluid depletion in both adult and pediatric populations. Glucose 5% is also used as a vehicle and diluent for compatible medicinal products for parenteral administration.
The following are primary indications for the use of 5% Glucose infusion:
• For fluid and carbohydrate depletion wherever a non-electrolyte fluid is required
• In the treatment of hypoglycemia.
• In the treatment of acute diarrhoeal disease.
• As a vehicle for the administration of other medications.
The infusion of hypertonic glucose ( 10%) preparations are contraindicated in patients:
• With hypersensitivity to the active substance or to any of the excipients
• Having intracranial or intraspinal haemorrhage.
• With delirium tremens or those who are severely dehydrated.
• Who are anuric.
• With diabetic coma.
Dosage will be dependent upon individual patient circumstances, such as age, weight and clinical condition, and is determined by the attending physician.
This solution is also used:
• For immediate replenishment of blood volume after blood loss,
• As a vehicle to deliver other electrolytes or medicinal products,
• For treatment of wounds and moistening of wound tamponades and dressings.
•
Available as:
IV Drips
• 100ml
• 500ml
• 1000ml

Address

Sheikh Zyed Road
Rahimyar Khan
64200

Telephone

+923344519519

Website

http://www.lakhanipharma.com/

Alerts

Be the first to know and let us send you an email when Lakhani Pharma Pvt. Ltd posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Lakhani Pharma Pvt. Ltd:

Shortcuts

Want your practice to be the top-listed Clinic in Rahimyar Khan?